Related references
Note: Only part of the references are listed.New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Scintigraphic pattern of skeletal involvement of Waldenstrom macroglobulinemia
Magda S. Elmonayeri et al.
CLINICAL NUCLEAR MEDICINE (2008)
Current treatment options for Waldenstrom macroglobulinemia
Arun Vijay et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Early therapeutic response assessment by 18 FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure
Ashley P. Ng et al.
LEUKEMIA & LYMPHOMA (2007)
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia
IM Ghobrial et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia
Eva Kimby et al.
CLINICAL LYMPHOMA & MYELOMA (2006)
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma
T Torizuka et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Uniform response criteria in Waldenstrom's macroglobulinemia:: Consensus panel recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia
D Weber et al.
SEMINARS IN ONCOLOGY (2003)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RG Owen et al.
SEMINARS IN ONCOLOGY (2003)
Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)
F Najjar et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)
G Jerusalem et al.
ANNALS OF ONCOLOGY (2001)
18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT
NG Mikhaeel et al.
LEUKEMIA & LYMPHOMA (2000)
The impact of FDG positron emission tomography imaging on the management of lymphomas
N Shah et al.
BRITISH JOURNAL OF RADIOLOGY (2000)
Share Paper
